Andan, Erlinda .
HRN: 25-34-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/13/2024
07/19/2024
TOPICAL
1%
BID
Pressure Blisters Or Ulcers
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes